Price and VolumeDetailed Quote
Top NewsMore NewsPerformance
More NewsRead More
Johnson & Johnson Seeks FDA Approval For Muscle Weakness Drug And Gears Up Showdown With Argenx and UCB
August 29, 2024
Via Benzinga
Exposures
Product Safety
UCB's Rare Childhood Epilepsy Drug Scores FDA Approval
March 28, 2022
Via Benzinga
Dianthus' Monoclonal Antibody On Promising Pathway To Gaining The Upper Hand - Analyst
September 28, 2023
Via Benzinga
Via Benzinga
Via Benzinga
Via Benzinga
UCB Gets EU Approval For Bimekizumab In Psoriasis
August 25, 2021
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|